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http://www.annalsofintensivecare.com/content/3/1/25RESEARCH Open AccessComparison of thermodilution measured
extravascular lung water with chest radiographic
assessment of pulmonary oedema in patients
with acute lung injury
Lisa M Brown1,2, Carolyn S Calfee3,4, James P Howard2,5, Thelma R Craig6,7, Michael A Matthay2,3,8*
and Daniel F McAuley6,7Abstract
Background: Acute lung injury and the acute respiratory distress syndrome (ALI/ARDS) are characterized by
pulmonary oedema, measured as extravascular lung water (EVLW). The chest radiograph (CXR) can potentially
estimate the quantity of lung oedema while the transpulmonary thermodilution method measures the amount of
EVLW. This study was designed to determine whether EVLW as estimated by a CXR score predicts EVLW measured
by the thermodilution method and whether changes in EVLW by either approach predict mortality in ALI/ARDS.
Methods: Clinical data were collected within 48 hours of ALI/ARDS diagnosis and daily up to 14 days on 59
patients with ALI/ARDS. Two clinicians scored each CXR for the degree of pulmonary oedema, using a validated
method. EVLW indexed to body weight was measured using the single indicator transpulmonary thermodilution
technique.
Results: The CXR score had a modest, positive correlation with the EVLWI measurements (r = 0.35, p < 0.001). There
was a 1.6 ml/kg increase in EVLWI per 10-point increase in the CXR score (p < 0.001, 95% confidence interval 0.92-
2.35). The sensitivity of a high CXR score for predicting a high EVLWI was 93%; similarly the negative predictive
value was high at 94%; the specificity (51%) and positive predictive value (50%) were lower. The CXR scores did not
predict mortality but the EVLW thermodilution did predict mortality.
Conclusion: EVLW measured by CXR was modestly correlated with thermodilution measured EVLW. Unlike CXR
findings, transpulmonary thermodilution EVLWI measurements over time predicted mortality in patients with ALI/ARDS.
Keywords: Extravascular lung water, Chest radiograph, Acute lung injury, Acute respiratory distress syndromeBackground
Acute lung injury and the acute respiratory distress syn-
drome (ALI/ARDS) are characterized by an increase in
pulmonary capillary permeability to protein leading to
extravasation of protein-rich oedema fluid, known as
extravascular lung water (EVLW), into the alveoli [1,2].
Importantly, the quantity of EVLW measured early in
the course of ALI can predict survival [3,4] Therefore,
quantitative and accurate measure of EVLW may be a* Correspondence: michael.matthay@ucsf.edu
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in any medium, provided the original work is pvaluable tool for assessment of this patient population.
Furthermore, successive and reliable estimates of EVLW
could be an effective guide to fluid management and di-
uretic therapy, potentially offering a superior approach
to the contemporary clinical strategies used in patients
with ALI/ARDS [5-7]. Therefore, methods to accurately
quantify the amount of EVLW may be of value to clini-
cians who treat patients with ALI/ARDS.
The most commonly used method to estimate the
amount of EVLW is the chest radiograph [8]. EVLW also
may be measured at the bedside using transpulmonary
thermodilution methods [9-11]. Thermodilution methods
are invasive because they require that the patient haven Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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unclear whether these two methods of evaluating EVLW
provide similar information to the clinician. If the chest
radiograph findings can accurately predict the amount of
EVLW, then it may not be necessary to use invasive
methods to measure EVLW. However, if not, measuring
EVLW may contribute additional useful information in
critically ill patients with ALI/ARDS.
Several early studies of critically ill patients with pulmo-
nary oedema reported that serial chest radiographs were
not useful for estimating absolute or changes in the EVLW
[12]. These studies found a moderate positive correlation
between the chest radiograph findings and the quantity of
EVLW measured with either the gravimetric or transpul-
monary thermodilution methods [12-17]. However, all of
these studies were done more than 20 years ago, and since
that time both the technology of portable chest radio-
graphs and measurement of EVLW have improved
[18,19]. Furthermore, using an objective chest radiograph
scoring system may improve the ability to measure pul-
monary oedema using chest radiograph findings [20].
Prior studies comparing the chest radiograph with EVLW
measured using the thermodilution method used double
indicator methods to measure the amount of EVLW
[12,14-17]. Currently, the most common thermodilution
method of measuring EVLW is the single-indicator
transpulmonary thermodilution method (PiCCO, Pulsion
Medical Systems, Munich, Germany) [9]. This method has
been validated by comparison with the “gold standard”
gravimetric method in experimental animal studies
[21-23]. Several investigators have studied EVLW in critic-
ally ill patients [24-31]. There is some evidence that
EVLW measured by the single-indicator transpulmonary
thermodilution method early in the course of ALI/ARDS,
particularly if indexed to predicted body weight, is associ-
ated with poor outcome [3,32].
The main purpose of this study was to determine
whether a chest radiograph score that has been recently
validated [33] could predict EVLW measured using the
transpulmonary thermodilution method in patients with
ALI/ARDS. We also determined whether changes in
EVLW on consecutive ICU days as measured by the chest
radiograph and the transpulmonary thermodilution method
predict ventilator-free days and mortality in patients with
ALI/ARDS.
Methods
Subjects
Patients for this study were enrolled in a randomized, clin-
ical trial investigating the effects of simvastatin on EVLW
in patients with ALI/ARDS [34]. Patients were eligible for
enrollment if they met the American-European Consensus
Conference criteria for ALI or ARDS [35]. The exclusion
criteria included creatine kinase (CK) >10 times upperlimit normal range, liver transaminases >3 times upper
limit normal range, patients with severe renal impairment
(calculated creatinine clearance <30 ml/min) not receiving
renal replacement therapy, patients with severe liver dis-
ease (Child’s Pugh score >11), known lactose intolerance,
current treatment with any lipid lowering agent including
statins, contraindications to enteral drug administration;
age <18 years; pregnancy; participation in a clinical trial
with an investigational medicinal product within 30 days,
unlikely to survive beyond 48 hours, and declined consent.
Baseline EVLW in the first 44 patients from this cohort
have been published elsewhere in a paper describing the
relationship between baseline EVLW indexed to predicted
body weight and mortality in ALI/ARDS [32]. Mechanic-
ally ventilated patients admitted to a 17-bed tertiary
referral center intensive care unit (ICU) in Northern
Ireland were prospectively screened for ALI/ARDS during
a 2-year period. The local institution and ethics committee
approved the protocol for the study, and all patients or
their surrogate provided informed consent.
Data collection
Clinical data were collected within 48 hours of diagnosis of
ALI/ARDS and once per day for up to 14 consecutive days.
The aetiology of ALI/ARDS was recorded, and patients
with pneumonia and septic shock requiring vasopressor
support were considered to have an infectious etiology.
Baseline Acute Physiology and Chronic Health Evaluation
Score (APACHE II), Simplified Acute Physiology Score
(SAPS II), Sequential Organ Failure Assessment (SOFA),
and Lung Injury Score (LIS) were determined for each
patient.
The PaO2/FiO2 ratio was calculated using arterial blood
gas samples and ventilator data. Ventilator parameters
recorded included tidal volume, respiratory rate, minute
ventilation, positive end expiratory pressure, mean airway
pressure, peak pressure, plateau pressure, and static re-
spiratory compliance.
Chest radiograph score
A chest radiograph scoring system was used by a two
clinician panel to score each chest radiograph who
interpreted the chest radiographs together at the same
time. Thus, separate interpretations were not done, so it
was not possible to assess interobserver variability by a
kappa value. The clinicians were blinded to the EVLWI
measurements. First, the quality of the chest radiograph
was classified as acceptable, borderline, or not usable.
Next, the probability of atelectasis (yes/no) was deter-
mined in each of the following four quadrants: right
upper (RU), right lower (RL), left upper (LU), left lower
(LL). Finally, the degree of alveolar oedema in each of
the four quadrants was scored as follows: 1) 0-25%, 2)
25-50%, 3) 50-75%, and 4) 75-100%. The middle value of
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categorize each of the chest radiograph quadrants as fol-
lows: 1) 12.5%, 2) 37.5%, 3) 62.5%, and 4) 87.5%. The
four alveolar oedema scores (RU, RL, LU, LL) for each
chest radiograph were totaled and divided by four to
generate an overall chest radiograph score. This scoring
system has been recently validated [33]. Chest radio-
graphs were taken daily between 9:00 and 10:00 A.M.
using portable equipment (exposure factor 90 kV,
1.4 mAs, a digital system).
EVLWI measurement
EVLW was measured within 48 hours of diagnosis of
ALI/ ARDS and once per day between 8:00 and 9:00
A.M. for up to 14 consecutive days using the single-
indicator transpulmonary thermodilution technique
(PiCCO Pulsion Medical Systems, Munich, Germany). A
15-mL bolus of 0.9% normal saline at 4°C was injec-
ted into a central venous catheter. The change in
temperature of this bolus was detected at the thermistor
tip of the femoral arterial line and a thermodilution
curve was generated. The EVLW was determined based
on the characteristics of the thermodilution curve [9].
Three bolus injections were used to calculate the mean
EVLW. The EVLW measurements were indexed to the
patients’ predicted body weight (EVLWI). EVLWI was
calculated by dividing the total EVLW by the predicted
body weight. The predicted body weight (in kilograms)
was calculated as 0.91 (height [cm] −152.4) + 50 for
males or + 45.5 for females. The clinicians treating the
patients had no knowledge of the results of the EVLWI
measurements.
Statistical analyses
The relationship between the chest radiograph score and
EVLWI measurements was graphed using scatterplots and
the correlation between the two was calculated using
Spearman’s correlation. Locally weighted scatterplot
smoothing (Lowess) was used to analyze the smoothed,
nonparametric relationship between CXR score, and
EVLWI. Linear regression was used to determine whether
the chest radiograph score predicts EVLWI. The model
was clustered by patient, in order to account for repeated
measures.
We determined the sensitivity, specificity, positive pre-
dictive value, and negative predictive value of the chest
radiograph scores using the transpulmonary thermodilution
EVLWI measurements as the “gold standard.” The EVLWI
measurements were split into two groups: high EVLWI
(≥16 ml/kg) and low EVLWI (<16 ml/kg) based on prior
data demonstrating that EVLWI ≥16 ml/kg predicted mor-
tality with 100% specificity and 86% sensitivity [3,32]. The
chest radiograph scores were also split into two groups:
high score (>85) and low score (≤85) based on analysis ofour data, in which one third of the scores were ≤85 and the
other two thirds were >85.
Next, we compared how well the baseline chest radio-
graph score, EVLWI, and PaO2/FiO2 predicted mortality
(within 30 days of hospital admission) and ventilator-
free days. The t test was used to determine whether the
baseline values of these three predictors differed between
survivors and nonsurvivors. Univariate logistic regres-
sion was used to determine whether these three baseline
values predicted ICU mortality. The area under the re-
ceiver operating characteristic curve was determined for
each of these three predictors and compared. Univariate
linear regression was used to determine whether these
three baseline values predicted ventilator-free days.
Finally, Cox regression was performed using the
chest radiograph score, EVLWI, and PaO2/FiO2 as time-
dependent covariates to determine whether the change in
each of these three variables predicts time to death. All pa-
tients were followed from the day of randomization until
hospital discharge or death. A follow-up time to and in-
cluding 30 days was used for this analysis. A p value < 0.05
was considered statistically significant. STATA SE version
10.1 (College Station, TX) was used for all statistical ana-
lyses, which were reviewed by a biostatistician.
Results
There were 59 patients included in these analyses and
476 total observations. The baseline characteristics of
the cohort are presented in Table 1. No patients were
lost to follow-up.
Correlation between chest radiograph score and EVLWI
measurements
The chest radiograph scores were positively, but mod-
estly, correlated with the EVLWI measurements (r =
0.35, p < 0.001; Figure 1). In an unadjusted linear model,
higher values of the chest radiograph score were associ-
ated with higher values of EVLWI. Specifically, there
was a 1.6 ml/kg increase in same day EVLWI per
10-point increase in chest radiograph score (p < 0.001,
95% confidence interval (CI) 0.92-2.35).
As we have done in a prior study [33], in order to inves-
tigate the potential confounding effect of atelectasis or
suboptimal chest radiographs, we performed additional
analyses, first excluding all observations with possible atel-
ectasis in any lung quadrant (remaining, n = 352) and sub-
sequently excluding all observations with poor radiograph
quality or possible atelectasis (remaining, n = 261). In both
sensitivity analyses, the correlations between the chest
radiograph score and EVLWI measurements were stron-
ger and there was a greater increase in EVLWI per in-
crease in chest radiograph score (Table 2).
The sensitivity of the chest radiograph score (cutoff
>85 based on prior published studies [3,24]) as a
Table 1 Baseline characteristics of the ALI/ARDS cohort
(n = 59)
Characteristic n = 59
Age 54 (38–64)
Male gender 45 (76%)
Etiology of ALI/ARDS
Trauma 19 (32%)
Pneumonia 11 (19%)
Aspiration 9 (15%)
Sepsis 9 (15%)
Pancreatitis 2 (3%)
Other/Unknown 9 (15%)
Extravascular lung water index (ml/kg) 11 (9–17)
Chest radiograph score 87.5 (68.75–87.5)
APACHE II score 25 (19-30)
SAPS II score 53 (42-63)
SOFA score 10 (8-12)
Lung injury score 2.5 (2-3)
Respiratory parameters
PaO2 / FiO2 170 (129–202)
Mean airway pressure 13 (9–16)
Peak airway pressure 22 (17–25)
Plateau pressure 22 (17–24)
Compliance 42 ± 15
Dead space fraction 0.58 (0.52–0.65)
Minute ventilation 9 (8–11)
Tidal volume 500 (427–560)
Respiratory rate 18 (15–20)
PEEP 8 (6–10)
Cardiovascular parameters
Heart rate 94 ± 19
Systolic blood pressure 116 (104–127)
Mean arterial pressure 78 (70–84)
Central venous pressure 12 ± 4
Data are median (interquartile range), number (%), or mean ± standard deviation.
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EVLWI as measured by the thermodilution method was
high (93%) as was the negative predictive value (94%).
However, the specificity (51%) and positive predictive
values (50%) were lower.
Chest radiograph score and EVLWI measurements and
outcomes
Mortality was 31%. The baseline chest radiograph score
and EVLWI were both higher in ICU nonsurvivors com-
pared with survivors (Table 3). The baseline PaO2/FiO2
ratio was not quite statistically significant in nonsur-
vivors (Table 4). In logistic regression models, thebaseline EVLWI and the PaO2/FiO2 predicted mortality,
and there was a trend towards statistical significance for
the ability of the baseline chest radiograph score to pre-
dict ICU mortality (Table 4). The areas under the re-
ceiver operating characteristic curves for each of the
three models were similar. The baseline chest radiograph
score and the PaO2/FiO2 ratio predicted ventilator free
days (Table 5). The changes in daily thermodilution
measured EVLWI measurements and PaO2/FiO2 ratio,
unlike the chest radiograph score, were predictive of
time to death (Table 6).
Discussion
The primary objectives of this study was to test the cor-
relation between pulmonary oedema assessed using the
single indicator transpulmonary thermodilution EVLWI
measurement and a validated chest radiograph score in
patients with ALI/ARDS as well as to test their predict-
ive value for mortality. There was only a moderate posi-
tive correlation between the chest radiograph findings
and the EVLWI measurement. This correlation was
lower, but similar to those of prior studies done more
than 20 years ago in which the correlation ranged from
r = 0.45-0.83 [12-15]. As a dichotomous test, a chest
radiograph score >85 was sensitive in determining
whether EVLW is present, but a score >85 was not spe-
cific for EVLW ≥16 ml/kg.
Using the single-indicator transpulmonary thermodi-
lution method to measure EVLWI is attractive for many
reasons. First, this method generates a quantitative
measure of EVLW, in contrast to the chest radiograph,
which must be interpreted qualitatively by clinicians and
is susceptible to interobserver disagreement. We tried to
reduce interobserver variability by using an objective
validated chest radiograph scoring system [33]. Once
ALI/ARDS is established, current practice relies on clini-
cians accurately interpreting successive chest radio-
graphs to determine whether pulmonary oedema is
accumulating or resolving. Although chest radiographs
are relatively inexpensive, readily available, and noninva-
sive, quantitative measures are clinically more useful
than qualitative measures. For example, specific cutoffs
in a quantitative measure such as EVLWI could be used
to guide patient management in a fluid management
protocol. Second, the chest radiograph is insensitive to
small changes in the quantity of EVLW present [36]. In
contrast, small changes (10-20%) in EVLW can be
detected using the single indicator method [37]. Detecting
small changes in EVLWI may allow for earlier diagnosis of
ALI/ARDS and more precise monitoring of responses to
therapeutic measures. Finally, lung inflation affects the ap-
pearance of the chest radiograph; likewise, atelectasis may
be difficult to differentiate from airspace opacities consist-
ent with alveolar oedema [38]. However, these potential
Figure 1 Scatter plot of extravascular lung water index (EVLWI) versus chest radiograph score with a Lowess smoothing line. EVLWI
measurements and chest radiograph scores are from all days for which data are available (n = 476).
Table 3 Baseline chest radiograph score, EVLWI, and
PaO2/FiO2 in ICU survivors and nonsurvivors
Baseline predictor Mean ± SD 95% CI p valuea
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must be weighed against the potential complications of
this invasive method, including the risk of bleeding at the
site of vascular access, arterial injury, and thrombosis.
The change in daily chest radiograph scores was not
predictive of time to death. In contrast, EVLWI changes
over consecutive ICU days predicted mortality. This
builds upon our previous data that baseline EVLWI > 16
ml/kg predicts mortality in ALI [32]. Other studies have
reported that EVLW may be an independent predictor
of mortality for ICU patients [4]. One study reported a
mortality rate of 65% when EVLW was >15 ml/kg [4],
and another found that EVLWI >16 ml/kg predicted
mortality with 100% specificity and 86% sensitivity [3].
In addition, EVLWI may have predictive value during
the entire clinical course because maximum EVLWI is a
predictor of mortality [3,4]. This is consistent with our
finding that the change in EVLWI measurements over
the ICU course was predictive of mortality. Taken to-
gether, these observations indicate that EVLWI measure-
ments may provide a quantitative assessment of lungTable 2 Correlation between chest radiograph score and
EVLWI measurements excluding chest radiographs of
borderline quality or with possible atelectasis and of
borderline quality
Possible atelectasis
excluded (n = 352)
Possible atelectasis
and borderline quality
excluded (n = 261)
Chest radiograph score
correlation with the EVLWI
r = 0.41, p < 0.001 r = 0.48, p < 0.001
Increase in EVLWI (ml/kg)a 1.8 p < 0.001,
95% CI (0.98–2.64)
2.0 p < 0.001,
95% CI (1.1–2.81)
aPer 10–point increase in chest radiograph score.injury severity, which could be used to guide therapy in
ALI/ARDS. Consistent with this, prior studies have
reported that EVLWI measurements can be successfully
used to monitor response to β agonist therapy [39,40].
The next step would be to design a clinical trial in which
EVLWI measurements are used to guide fluid and diuretic
therapy, and within this same trial, determine if decreases
in EVLW are associated with a decrease in mortality.
The threshold of 16 ml/kg for the EVLWI has been used
to identify ARDS patients with a higher mortality. This
level indicates a high amount of pulmonary oedema,
although levels between 10 and 15 ml/kg represent
progressive interstitial and alveolar oedema [41]. Some in-
vestigators have concluded that as many as 50% of patients
with a clinical diagnosis of ARDS have a normal EVLWI
[42], but more prospective data are needed to assess this
issue.Chest radiograph score
Survivors (n = 41) 74 ± 19 (68–80) 0.007
Nonsurvivors (n = 18) 84 ± 8 (79–88)
EVLWI
Survivors (n = 41) 12 ± 5 (11–14) 0.05
Nonsurvivors (n = 18) 17 ± 9 (12–21)
PaO2/FiO2
Survivors (n = 41) 179 ± 47 (164–194) 0.08
Nonsurvivors (n = 18) 146 ± 67 (110–181)
ap value for the difference in baseline predictor between survivors and
nonsurvivors, t test with unequal variance.
Table 6 Cox regression models for predicting death
Predictora Unadjusted
hazard ratio
p value 95% CI
Chest radiograph score 1.72 0.3 (0.59–4.99)
Extravascular lung water
index (ml/kg)
1.14 0.001 (1.05–1.23)
PaO2 / FiO2 0.83 0.003 (0.74–0.94)
aPer 10–point increase in chest radiograph score and PaO2/FiO2.
Table 4 Univariate logistic regression models for
predicting ICU mortality using baseline predictors
Predictora Unadjusted
odds ratio
p value 95% CI AUROCb
Chest radiograph score 1.77 0.07 (0.95–3.3) 0.66
Extravascular lung
water index (ml/kg)
1.12 0.03 (1.01–1.24) 0.68
PaO2 / FiO2 0.89 0.04 (0.79–0.99) 0.65
aPer 10–point increase in chest radiograph score and PaO2/FiO2.
bArea under the receiver operating characteristic curve.
No statistically significant difference between these three AUROCs, p = 0.9.
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ratio in nonsurvivors, and in logistic regression baseline
PaO2/FiO2 ratio predicted ventilator free days and mor-
tality. In addition, the change in PaO2/FiO2 ratio over
consecutive ICU days predicted time to death. Although
not consistent in all studies, baseline PaO2/FiO2 ratio
has been reported in some studies to be lower in
nonsurvivors [43-46] and predicts mortality in univariate
analyses [43,44,46]. In addition, in one large cohort
study, PaO2/FiO2 ratio was an independent predictor of
mortality [44]. However, these studies did not test the
change in PaO2/FiO2 ratio over consecutive ICU days as
a predictor of mortality. A limitation of PaO2/FiO2 ratio
as a predictor of outcome is the fact that it can be modi-
fied independently by adjustment in ventilatory settings,
a limitation to which measurement of EVLWI is not
susceptible.
The baseline chest radiograph score differed between
survivors and non-survivors, but in contrast to EVLWI
and PaO2/FiO2, did not predict mortality. The change in
daily chest radiograph scores did not predict time to
death although it did predict ventilator-free days. Most
prior studies of chest radiograph findings in patients
with pulmonary oedema examined the ability of the
chest radiograph to predict the amount of EVLW
present, not mortality [12,13,15,17,47]. Our chest radio-
graph scoring system is easy to apply clinically, has been
validated [33], and has a high sensitivity for the detec-
tion of EVLW.
Measurement of the EVLWI using the transpulmonary
thermodilution method may serve two important pur-
poses. First, measuring EVLWI using this method may be
useful to confirm the presence of an increase in pulmonaryTable 5 Univariate linear regression models for
predicting ventilator–free days using baseline predictors
Predictora Unadjusted β
coefficient
p value 95% CI
Chest radiograph score −1.75 0.007 (−2.99 to −0.51)
Extravascular lung water
index (ml/kg)
−0.18 0.3 (−0.53 to 0.17)
PaO2 / FiO2 0.41 0.04 (0.02–0.81)
aPer 10–point increase in chest radiograph score and PaO2/FiO2.oedema. In addition, by using the transpulmonary
thermodilution method, EVLWI is measured quantita-
tively. Trending the EVLWI measurements over consecu-
tive ICU days predicts mortality and may be of value for
guiding therapy.
Our study has some limitations. First, the total num-
ber of deaths (18/59 patients) limited our ability to per-
form a multivariable regression analysis controlling for
potentially confounding conditions that may affect the
risk of death. However, because we collected data on
multiple days for each patient, we did have sufficient
power to detect associations between the chest radio-
graph score and EVLWI. More importantly, we could
use Cox regression models to determine whether the
change in each of these predictors (chest radiograph
score, EVLWI, and PaO2/FiO2) over time predicted time
to death. Second, when scoring the chest radiographs,
we only considered the proportion of the airspace that
was affected, and not the density of the alveolar oedema.
Certain characteristic signs, such as pulmonary conges-
tion and vascular redistribution, are associated with
small increases in EVLW [8]. As the quantity of EVLW
increases, densities occupy a greater proportion of the total
airspace, and as EVLW further increases, the density of the
airspace opacities also worsens [8]. If we had accounted for
the density in addition to the proportion of airspace af-
fected, the correlation between the chest radiograph score
and EVLWI might have been stronger, and chest radio-
graph score may have been predictive of mortality. Third,
many of the chest radiographs were scored at the max-
imum chest radiograph score. It would have been ideal to
have chest radiograph scores distributed more evenly across
the entire scoring range to provide more variability to de-
termine how these scores match with the wide range of
EVLWI measurements. Fourth, we did not use the PiCCO
device to estimate lung vascular permeability, which other
investigators have used [48]. Fifth, we did not quantify
pleural effusions by ultrasound or CT [49], and sixth, we
did not quantify fluid balance in these patients [50].
Conclusions
EVLW measured by the chest radiograph only modestly
predicted EVLWI as measured by the transpulmonary
thermodilution technique. However, unlike the chest
radiograph score, transpulmonary thermodilution EVLWI
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in patients with ALI/ARDS, as others have reported
[51,52]. Because it is quantitative and sensitive, and pre-
dicts mortality, measurement of EVLWI using single-
indicator transpulmonary thermodilution may provide
rapidly available and specific information at the bedside in
ALI/ARDS. These characteristics suggest that this meas-
urement may be a valuable resource as a prognostic and
assessment tool, in both clinical practice and research
studies, although prospective studies will be needed to test
this hypothesis further.
Competing interests
None of the authors have a financial relationship with a commercial entity
that has an interest in the subject of this manuscript.
Authors’ contributions
LB, CC, MM and DM designed the study. LB, CC, JH and TC contributed to
data collection and chest radiograph interpretations. LB and CC analyzed the
data. All authors contributed to interpretation of the study results. LB wrote
the first draft of the manuscript. All authors reviewed the manuscript and
approved the final draft.
Acknowledgment
The authors appreciate the assistance of Andrew Manies in the preparation
of this manuscript.
Funding
Dr. Brown was supported by NIH T32 GM008258-21. Dr. Calfee was
supported by the NIH HL090833 and the Flight Attendant Medical Research
Institute. Dr. Howard is a Fellow of the Pediatric Scientist Development
Program, and was supported by K12-HD000850 from the Eunice Kennedy
Shriver National Institute of Child Health and Human Development,
Dr. Matthay was supported by NHLBI HL51856. Dr Craig was supported by
the NI Public Health Agency (PHA) Research and Development Division
(RDD). Prof McAuley was supported by the NI PHA RDD Translational
Research Group for Critical Care.
Author details
1Department of Surgery, Division of Cardiothoracic Surgery, Washington
University, St. Louis, MO, USA. 2Cardiovascular Research Institute, University of
California, San Francisco, CA, USA. 3Department of Medicine, Division of
Pulmonary and Critical Care, University of California, San Francisco, CA, USA.
4Department of Anesthesia, University of California, San Francisco, CA, USA.
5Department of Pediatrics, Division of Critical Care Medicine, University of
California, San Francisco, CA, USA. 6Regional Intensive Care Unit, Royal Victoria
Hospital, Belfast, UK. 7Centre for Infection and Immunity, The Queen’s University of
Belfast, Belfast, UK. 8University of California, 505 Parnassus Avenue, Room M-917,
San Francisco, CA 94143-0624, USA.
Received: 14 March 2013 Accepted: 29 July 2013
Published: 11 August 2013
References
1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med
2000, 342:1334–1349.
2. Matthay MA, Ware LB, Zimmerman GA: The acute respiratory distress
syndrome. J Clin Invest 2012, 122:2731–2740.
3. Phillips CR, Chesnutt MS, Smith SM: Extravascular lung water in sepsis-associated
acute respiratory distress syndrome: indexing with predicted body weight
improves correlation with severity of illness and survival. Crit Care Med 2008,
36:69–73.
4. Sakka SG, Klein M, Reinhart K, Meier-Hellmann A: Prognostic value of
extravascular lung water in critically ill patients. Chest 2002, 122:2080–2086.
5. Eisenberg PR, Hansbrough JR, Anderson D, Schuster DP: A prospective
study of lung water measurements during patient management in an
intensive care unit. Am Rev Respir Dis 1987, 136:662–668.6. Mitchell JP, Schuller D, Calandrino FS, Schuster DP: Improved outcome
based on fluid management in critically ill patients requiring pulmonary
artery catheterization. Am Rev Respir Dis 1992, 145:990–998.
7. Verheij J, van Lingen A, Raijmakers PG, Rijnsburger ER, Veerman DP,
Wisselink W, Girbes AR, Groeneveld AB: Effect of fluid loading with saline
or colloids on pulmonary permeability, oedema and lung injury score
after cardiac and major vascular surgery. Br J Anaesth 2006, 96:21–30.
8. Lange NR, Schuster DP: The measurement of lung water. Crit Care 1999,
3:R19–R24.
9. Brown LM, Liu KD, Matthay MA: Measurement of extravascular lung water
using the single indicator method in patients: research and potential
clinical value. Am J Physiol Lung Cell Mol Physiol 2009, 297:L547–L558.
10. Lewis FR, Elings VB, Hill SL, Christensen JM: The measurement of
extravascular lung water by thermal-green dye indicator dilution. Ann N
Y Acad Sci 1982, 384:394–410.
11. Sakka SG, Ruhl CC, Pfeiffer UJ, Beale R, McLuckie A, Reinhart K, Meier-Hellmann
A: Assessment of cardiac preload and extravascular lung water by single
transpulmonary thermodilution. Intensive Care Med 2000, 26:180–187.
12. Halperin BD, Feeley TW, Mihm FG, Chiles C, Guthaner DF, Blank NE:
Evaluation of the portable chest roentgenogram for quantitating
extravascular lung water in critically ill adults. Chest 1985, 88:649–652.
13. Snashall PD, Keyes SJ, Morgan BM, McAnulty RJ, Mitchell-Heggs PF, McLvor
JM, Howlett KA: The radiographic detection of acute pulmonary oedema.
A comparison of radiographic appearances, densitometry and lung
water in dogs. Br J Radiol 1981, 54:277–288.
14. Pistolesi M, Giuntini C: Assessment of extravascular lung water. Radiol Clin
North Am 1978, 16:551–574.
15. Laggner A, Kleinberger G, Haller J, Lenz K, Sommer G, Druml W: Bedside
estimation of extravascular lung water in critically ill patients:
comparison of the chest radiograph and the thermal dye technique.
Intensive Care Med 1984, 10:309–313.
16. Baudendistel L, Shields JB, Kaminski DL: Comparison of double indicator
thermodilution measurements of extravascular lung water (EVLW) with
radiographic estimation of lung water in trauma patients. J Trauma 1982,
22:983–988.
17. Sibbald WJ, Warshawski FJ, Short AK, Harris J, Lefcoe MS, Holliday RL:
Clinical studies of measuring extravascular lung water by the thermal
dye technique in critically ill patients. Chest 1983, 83:725–731.
18. Trotman-Dickenson B: Radiology in the intensive care unit (Part I).
J Intensive Care Med 2003, 18:198–210.
19. McAdams HP, Samei E, Dobbins J 3rd, Tourassi GD, Ravin CE: Recent
advances in chest radiography. Radiology 2006, 241:663–683.
20. Neyrinck AP, O’Neal H, Lee JW, Curtis B, Matthay MA, Ware L: Quantification
of pulmonary oedema on chest radiograph compared with direct
measurements of extravascular lung water in humans. Am J Respir Crit
Care Med 2009, 179:A3385.
21. Katzenelson R, Perel A, Berkenstadt H, Preisman S, Kogan S, Sternik L, Segal E:
Accuracy of transpulmonary thermodilution versus gravimetric
measurement of extravascular lung water. Crit Care Med 2004, 32:1550–1554.
22. Kirov MY, Kuzkov VV, Kuklin VN, Waerhaug K, Bjertnaes LJ: Extravascular
lung water assessed by transpulmonary single thermodilution and
postmortem gravimetry in sheep. Crit Care 2004, 8:R451–R458.
23. Rossi P, Wanecek M, Rudehill A, Konrad D, Weitzberg E, Oldner A: Comparison of
a single indicator and gravimetric technique for estimation of extravascular
lung water in endotoxemic pigs. Crit Care Med 2006, 34:1437–1443.
24. Berkowitz DM, Danai PA, Eaton S, Moss M, Martin GS: Accurate
characterization of extravascular lung water in acute respiratory distress
syndrome. Crit Care Med 2008, 36:1803–1809.
25. Mallat J, Pepy F, Lemyze M, Barrailler S, Gasan G, Tronchon L, Thevenin D:
Extravascular lung water indexed or not to predicted body weight is a
predictor of mortality in septic shock patients. J Crit Care 2012, 27:376–383.
26. Chew MS, Ihrman L, During J, Bergenzaun L, Ersson A, Unden J, Ryden J,
Akerman E, Larsson M: Extravascular lung water index improves the diagnostic
accuracy of lung injury in patients with shock. Crit Care 2012, 16:R1.
27. Huber W, Mair S, Gotz SQ, Tschirdewahn J, Siegel J, Schmid RM, Saugel B:
Extravascular lung water and its association with weight, height, age,
and gender: a study in intensive care unit patients. Intensive Care Med
2013, 39:146–150.
28. Wolf S, Riess A, Landscheidt JF, Lumenta CB, Schurer L, Friederich P: How to
perform indexing of extravascular lung water: a validation study.
Crit Care Med 2013, 41:990–998.
Brown et al. Annals of Intensive Care 2013, 3:25 Page 8 of 8
http://www.annalsofintensivecare.com/content/3/1/2529. Jozwiak M, Silva S, Persichini R, Anguel N, Osman D, Richard C, Teboul JL, Monnet
X: Extravascular lung water is an independent prognostic factor in patients
with acute respiratory distress syndrome. Crit Care Med 2013, 41:472–480.
30. Saugel B, Holzapfel K, Stollfuss J, Schuster T, Phillip V, Schultheiss C, Schmid
RM, Huber W: Computed tomography to estimate cardiac preload and
extravascular lung water. A retrospective analysis in critically ill patients.
Scand J Trauma Resusc Emerg Med 2011, 19:31.
31. Saugel B, Ringmaier S, Holzapfel K, Schuster T, Phillip V, Schmid RM, Huber
W: Physical examination, central venous pressure, and chest radiography
for the prediction of transpulmonary thermodilution-derived
hemodynamic parameters in critically ill patients: a prospective trial.
J Crit Care 2011, 26:402–410.
32. Craig TR, Duffy MJ, Shyamsundar M, McDowell C, McLaughlin B, Elborn JS,
McAuley DF: Extravascular lung water indexed to predicted body weight
is a novel predictor of intensive care unit mortality in patients with
acute lung injury. Crit Care Med 2010, 38:114–120.
33. Ware LB, Neyrinck A, O’Neal HR, Lee JW, Landeck M, Johnson E, Calfee CS,
Matthay MA, the California Transplant Donor N: Comparison of chest
radiograph scoring to lung weight as a quantitative index of pulmonary
oedema in organ donors. Clin Transplant 2012, 26:665–671.
34. Craig TR, Duffy MJ, Shyamsundar M, McDowell C, O’Kane CM, Elborn JS,
McAuley DF: A randomized clinical trial of hydroxymethylglutaryl-
coenzyme a reductase inhibition for acute lung injury (The HARP Study).
Am J Respir Crit Care Med 2011, 183:620–626.
35. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M,
Legall JR, Morris A, Spragg R: The American-European Consensus
Conference on ARDS. Definitions, mechanisms, relevant outcomes, and
clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818–824.
36. Wheeler AP, Carroll FE, Bernard GR: Radiographic issues in adult
respiratory distress syndrome. New Horiz 1993, 1:471–477.
37. Fernandez-Mondejar E, Rivera-Fernandez R, Garcia-Delgado M, Touma A,
Machado J, Chavero J: Small increases in extravascular lung water are
accurately detected by transpulmonary thermodilution. J Trauma 2005,
59:1420–1423. discussion 1424.
38. Trotman-Dickenson B: Radiology in the intensive care unit (part 2).
J Intensive Care Med 2003, 18:239–252.
39. Perkins GD, McAuley DF, Thickett DR, Gao F: The beta-agonist lung injury
trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir
Crit Care Med 2006, 173:281–287.
40. Licker M, Tschopp JM, Robert J, Frey JG, Diaper J, Ellenberger C: Aerosolized
salbutamol accelerates the resolution of pulmonary oedema after lung
resection. Chest 2008, 133:845–852.
41. Eichhorn V, Goepfert MS, Eulenburg C, Malbrain ML, Reuter DA:
Comparison of values in critically ill patients for global end-diastolic
volume and extravascular lung water measured by
transcardiopulmonary thermodilution: a meta-analysis of the literature.
Med Intensiva 2012, 36:467–474.
42. Michard F, Zarka V, Alaya S: Better characterization of acute lung injury/
ARDS using lung water. Chest 2004, 125:1166. author reply 1167.
43. Estenssoro E, Dubin A, Laffaire E, Canales H, Saenz G, Moseinco M, Pozo M,
Gomez A, Baredes N, Jannello G, Osatnik J: Incidence, clinical course, and
outcome in 217 patients with acute respiratory distress syndrome. Crit
Care Med 2002, 30:2450–2456.
44. Cooke CR, Kahn JM, Caldwell E, Okamoto VN, Heckbert SR, Hudson LD,
Rubenfeld GD: Predictors of hospital mortality in a population-based cohort
of patients with acute lung injury. Crit Care Med 2008, 36:1412–1420.
45. Cooke CR, Shah CV, Gallop R, Bellamy S, Ancukiewicz M, Eisner MD, Lanken PN,
Localio AR, Christie JD: A simple clinical predictive index for objective
estimates of mortality in acute lung injury. Crit Care Med 2009, 37(6):1913–1920.
46. Nuckton TJ, Alonso JA, Kallet RH, Daniel BM, Pittet JF, Eisner MD, Matthay
MA: Pulmonary dead-space fraction as a risk factor for death in the
acute respiratory distress syndrome. N Engl J Med 2002, 346:1281–1286.
47. Sivak ED, Richmond BJ, O’Donavan PB, Borkowski GP: Value of
extravascular lung water measurement vs portable chest x-ray in the
management of pulmonary oedema. Crit Care Med 1983, 11:498–501.
48. Monnet X, Anguel N, Osman D, Hamzaoui O, Richard C, Teboul JL:
Assessing pulmonary permeability by transpulmonary thermodilution
allows differentiation of hydrostatic pulmonary oedema from ALI/ARDS.
Intensive Care Med 2007, 33:448–453.49. Deeren DH, Dits H, Daelemans R, Malbrain ML: Effect of pleural fluid on
the measurement of extravascular lung water by single transpulmonary
thermodilution. Clinical Intensive Care 2004, 15:119–122.
50. Cordemans C, De Laet I, Van Regenmortel N, Schoonheydt K, Dits H, Huber
W, Malbrain ML: Fluid management in critically ill patients: the role of
extravascular lung water, abdominal hypertension, capillary leak, and
fluid balance. Ann Intensive Care 2012, 2(Suppl 1):S1.
51. Cordemans C, De Laet I, Van Regenmortel N, Schoonheydt K, Dits H, Martin
G, Huber W, Malbrain ML: Aiming for a negative fluid balance in patients
with acute lung injury and increased intra-abdominal pressure: a pilot
study looking at the effects of PAL-treatment. Ann Intensive Care 2012,
2(Suppl 1):S15.
52. Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR: A
randomized, controlled trial of furosemide with or without albumin in
hypoproteinemic patients with acute lung injury. Crit Care Med 2005,
33:1681–1687.
doi:10.1186/2110-5820-3-25
Cite this article as: Brown et al.: Comparison of thermodilution
measured extravascular lung water with chest radiographic assessment
of pulmonary oedema in patients with acute lung injury. Annals of
Intensive Care 2013 3:25.Submit your manuscript to a 
journal and benefi t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the fi eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
